Aspen expects Mounjaro Africa sales above $124 million in current year
Aspen Pharmacare expects African sales of Eli Lilly’s Mounjaro to exceed 2 billion rand (about $124 million) in its current financial year, citing strong South Africa demand and planned launches in Nigeria and Kenya.
By Nqobile DludlaAspen Pharmacare JSE:APN expects African sales of Eli Lilly's NYSE:LLY blockbuster weight-loss and diabetes drug Mounjaro to exceed 2 billion rand ($124 million) in its current financial year, buoyed by surging demand in South Africa and planned launches in Nigeria and Kenya.The So…